ZACROS Past Earnings Performance
Past criteria checks 3/6
ZACROS's earnings have been declining at an average annual rate of -5%, while the Chemicals industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 4.2% per year. ZACROS's return on equity is 5.9%, and it has net margins of 3.5%.
Key information
-5.0%
Earnings growth rate
-4.8%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 4.2% |
| Return on equity | 5.9% |
| Net Margin | 3.5% |
| Next Earnings Update | 06 Feb 2025 |
Revenue & Expenses Breakdown
How ZACROS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 142,731 | 5,004 | 17,174 | 4,431 |
| 31 Mar 24 | 136,155 | 4,532 | 16,347 | 4,431 |
| 31 Dec 23 | 131,978 | 3,569 | 16,902 | 3,759 |
| 30 Sep 23 | 129,023 | 4,678 | 16,339 | 3,759 |
| 30 Jun 23 | 127,909 | 4,310 | 15,756 | 3,759 |
| 31 Mar 23 | 129,364 | 4,854 | 15,498 | 3,759 |
| 31 Dec 22 | 132,077 | 6,148 | 15,375 | 3,545 |
| 30 Sep 22 | 132,249 | 7,108 | 15,211 | 3,545 |
| 30 Jun 22 | 129,947 | 7,789 | 14,984 | 3,545 |
| 31 Mar 22 | 127,819 | 7,693 | 14,224 | 3,545 |
| 31 Dec 21 | 125,117 | 7,858 | 14,280 | 3,038 |
| 30 Sep 21 | 120,613 | 7,720 | 13,685 | 3,038 |
| 30 Jun 21 | 119,117 | 7,491 | 13,104 | 3,038 |
| 31 Mar 21 | 117,250 | 7,278 | 12,875 | 3,038 |
| 31 Dec 20 | 114,443 | 6,043 | 12,675 | 2,978 |
| 30 Sep 20 | 114,765 | 5,960 | 12,519 | 2,978 |
| 30 Jun 20 | 115,052 | 5,805 | 12,606 | 2,978 |
| 31 Mar 20 | 114,304 | 5,328 | 12,667 | 2,978 |
| 31 Dec 19 | 114,731 | 5,806 | 12,794 | 2,722 |
| 30 Sep 19 | 116,247 | 6,031 | 12,874 | 2,722 |
| 30 Jun 19 | 113,771 | 5,871 | 12,681 | 2,722 |
| 31 Mar 19 | 112,216 | 5,532 | 12,561 | 2,722 |
| 31 Dec 18 | 110,051 | 4,976 | 12,329 | 2,775 |
| 30 Sep 18 | 107,576 | 4,870 | 12,108 | 2,775 |
| 30 Jun 18 | 108,151 | 5,246 | 11,992 | 2,775 |
| 31 Mar 18 | 108,205 | 5,352 | 11,906 | 2,775 |
| 31 Dec 17 | 107,838 | 3,957 | 12,018 | 2,619 |
| 30 Sep 17 | 105,997 | 3,668 | 11,771 | 2,619 |
| 30 Jun 17 | 102,875 | 3,184 | 11,455 | 2,619 |
| 31 Mar 17 | 98,421 | 2,720 | 11,265 | 2,619 |
| 31 Dec 16 | 96,798 | 3,859 | 11,035 | 2,488 |
| 30 Sep 16 | 95,487 | 4,283 | 10,664 | 2,488 |
| 30 Jun 16 | 94,462 | 4,366 | 10,707 | 2,488 |
| 31 Mar 16 | 95,541 | 4,921 | 10,531 | 2,488 |
| 31 Dec 15 | 95,360 | 5,409 | 10,936 | 2,382 |
| 30 Sep 15 | 95,794 | 5,269 | 10,927 | 2,382 |
| 30 Jun 15 | 96,305 | 5,594 | 10,544 | 2,382 |
| 31 Mar 15 | 95,002 | 5,455 | 10,225 | 2,382 |
| 31 Dec 14 | 93,280 | 5,623 | 9,780 | 2,196 |
| 30 Sep 14 | 89,952 | 5,532 | 9,335 | 2,196 |
| 30 Jun 14 | 88,206 | 4,950 | 9,165 | 2,196 |
| 31 Mar 14 | 87,450 | 4,966 | 8,890 | 2,196 |
| 31 Dec 13 | 85,614 | 4,732 | 8,604 | 2,067 |
Quality Earnings: 7917 has a large one-off loss of ¥2.5B impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 7917's current net profit margins (3.5%) are higher than last year (3.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7917's earnings have declined by 5% per year over the past 5 years.
Accelerating Growth: 7917's earnings growth over the past year (16.1%) exceeds its 5-year average (-5% per year).
Earnings vs Industry: 7917 earnings growth over the past year (16.1%) exceeded the Chemicals industry 14%.
Return on Equity
High ROE: 7917's Return on Equity (5.9%) is considered low.